|
Volumn 313, Issue 2, 2015, Pages 131-132
|
Exceptional opportunities in medical science: A view from the National Institutes of Health
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CAUSE OF DEATH;
COST BENEFIT ANALYSIS;
ELECTRONIC MEDICAL RECORD;
FUNDING;
HEALTH CARE COST;
HUMAN;
INVESTMENT;
LIFE THREAT;
LIFESPAN;
MEDICAL RESEARCH;
NATIONAL HEALTH ORGANIZATION;
NONHUMAN;
PERSONALIZED MEDICINE;
PUBLIC HEALTH PROBLEM;
SHORT SURVEY;
STEM CELL RESEARCH;
BRAIN DISEASE;
COMMUNICABLE DISEASE;
ECONOMICS;
FINANCIAL MANAGEMENT;
GENOMICS;
PUBLIC HEALTH;
STEM CELL;
TRENDS;
UNITED STATES;
BIOMEDICAL RESEARCH;
BRAIN DISEASES;
COMMUNICABLE DISEASES;
GENOMICS;
HUMANS;
INDIVIDUALIZED MEDICINE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
PUBLIC HEALTH;
RESEARCH SUPPORT AS TOPIC;
STEM CELLS;
UNITED STATES;
|
EID: 84920946214
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2014.16736 Document Type: Short Survey |
Times cited : (63)
|
References (9)
|